- Report
- October 2025
- 194 Pages
Global
From €5215EUR$5,850USD£4,544GBP
- Report
- October 2025
- 263 Pages
Global
From €5215EUR$5,850USD£4,544GBP
- Report
- October 2025
- 293 Pages
Global
From €5215EUR$5,850USD£4,544GBP
- Report
- October 2025
- 260 Pages
Global
From €5215EUR$5,850USD£4,544GBP
- Report
- October 2025
- 411 Pages
Global
From €5215EUR$5,850USD£4,544GBP
- Report
- October 2025
- 196 Pages
Global
From €5215EUR$5,850USD£4,544GBP
- Report
- October 2025
- 292 Pages
Global
From €5215EUR$5,850USD£4,544GBP
- Report
- October 2025
- 193 Pages
Global
From €5215EUR$5,850USD£4,544GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €2140EUR$2,400USD£1,864GBP
€2675EUR$3,000USD£2,330GBP
- Report
- July 2025
Global
From €4368EUR$4,900USD£3,806GBP
- Report
- October 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,488GBP
- Report
- October 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,488GBP
- Report
- October 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,488GBP
- Report
- October 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,488GBP
- Report
- October 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,488GBP
- Report
- October 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,488GBP
- Report
- October 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,488GBP
- Report
- October 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,488GBP
- Report
- October 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,488GBP
- Report
- October 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,488GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more